Tom Jordan: I wish to be known for Taxol, carboplatin, and camaraderie

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

My first ASCO memories were back almost four decades ago (The Cancer Letter, June 3, 2022). 

I read with interest the contributions of others back in those days, and some of them mentioned me and Bristol-Myers Squibb and events we hosted. Some comments sounded a bit critical, but those were different times. 

Back then, the oncologists, the oncology nurses, and some of us BMS folks were in the battle against cancer together. 

Back then, the oncologists, the oncology nurses, and some of us BMS folks were in the battle against cancer together.

Some remembered the telephone booths at the BMS exhibit at the ASCO annual meeting. Others remembered the big parties we hosted, and came by the thousands to escape the stress of work to see The 5th Dimension, Lesley Gore, and the Four Tops. 

Others commented about the President’s Reception, which brought together the world leaders in cancer treatment. And, I noted a remark about me and my buddy, Bob Comis, doing our version of Frank Sinatra’s “My Way.” (I’m still singing it, but sadly without Bob. I am attaching a clip of it, in my 40-year-old green sports coat. It’s too big now. Haha.)

I can only hope that I and BMS will be remembered not for those events, but by the camaraderie we attempted to create. And, the establishment of the ASCO and the ONS Awards programs. As well as the thousands of clinical trials we conducted to bring more effective treatment to cancer patients, such as Taxol and carboplatin.

I’m attaching a recent photo. I’m 75 now, but still doing things MY way, here in the Philippines.

Thomas D. Jordon
Retired vice president of Worldwide Oncology Business, Bristol-Myers Squibb
Table of Contents

YOU MAY BE INTERESTED IN

Ivan Borrello, medical director of the Myeloma, Bone Marrow Transplant and Cell Therapies Program at Tampa General Hospital’s Cancer Institute, watched as flood waters from Hurricane Helene heaved against a contraption called the AquaFence, which is, as the name suggests, a water-impermeable barrier made of marine-grade laminate and various metals that can withstand storm surges of up to 15 feet above sea level. 
“When I joined ASCO in 2001, the most important thing to me was networking. I savored the opportunities to come to the annual meeting to meet and to talk with those who had led the studies that would inform standards of care, particularly in gynecologic oncology,” said Don S. Dizon. 
Thomas D. Jordon
Retired vice president of Worldwide Oncology Business, Bristol-Myers Squibb

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login